# GT Biopharma, Inc.: Form D funding, SEC 10-K (November 2026)

Registers read on November 19, 2026.

GT Biopharma, Inc. (California) appears in 2 public registers SpecStream reads: 12 Form D filings and 5 SEC annual and quarterly reports; the newest record is dated September 29, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 2
- Newest record: September 29, 2026
- State: California

## Form D filings (SEC)

12 Form D filings, newest September 29, 2026.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | September 29, 2026 | $7.8 million sold of $39 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000010965726000001/0000109657-26-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | May 28, 2025 | $0 sold of $20 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000164117225012695/0001641172-25-012695-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | May 27, 2025 | $6 million sold of $6 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000164117225012480/0001641172-25-012480-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | March 7, 2025 | $1.3 million sold of $1.3 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000010965725000002/0000109657-25-000002-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | July 23, 2020 | $5.6 million sold of an offering with no set size; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000165495420007958/0001654954-20-007958-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | June 12, 2020 | $2.4 million sold of an offering with no set size; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000165495420006561/0001654954-20-006561-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | August 17, 2018 | $5.1 million sold of $5.1 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000165495418009332/0001654954-18-009332-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | February 6, 2018 | $7.1 million sold of $7.1 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000165495418001133/0001654954-18-001133-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | September 14, 2017 | $4.5 million sold of $4.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000093979817000077/0000939798-17-000077-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657) | July 27, 2015 | $500 thousand sold of $1.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000093979815000050/0000939798-15-000050-index.htm) |

- [GT Biopharma, Inc.](https://specstream.ai/data/form-d/company/gt-biopharma-inc-109657)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=109657&type=D)

## Public company financials (SEC)

5 SEC annual and quarterly reports, newest March 2, 2026.

- SEC central index key (CIK): 109657
- Industry: SIC 2834, Pharmaceutical preparations
- Filer category: Non-accelerated filer

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [10-K filed March 2, 2026](https://specstream.ai/data/public-companies/company/109657-gt-biopharma-inc) | March 2, 2026 | SIC 2834, Pharmaceutical preparations | [sec.gov](https://www.sec.gov/Archives/edgar/data/109657/000149315226008443/0001493152-26-008443-index.htm) |

- [GT Biopharma, Inc.](https://specstream.ai/data/public-companies/company/109657-gt-biopharma-inc)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (California), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in California

- [Pharmaceutical companies in California, United States](https://specstream.ai/data/businesses/pharmaceutical-companies/california-united-states)
- [Pulmonology practices in California, United States](https://specstream.ai/data/businesses/pulmonology-practices/california-united-states)
- [Psychology practices in California, United States](https://specstream.ai/data/businesses/psychology-practices/california-united-states)
- [Produce wholesalers in California, United States](https://specstream.ai/data/businesses/produce-wholesalers/california-united-states)
- [Primary care clinics in California, United States](https://specstream.ai/data/businesses/primary-care-clinics/california-united-states)
- [Poke restaurants in California, United States](https://specstream.ai/data/businesses/poke-restaurants/california-united-states)
